| Stage | BOBS | % of rev | AVAH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $620M | 100.00% | $670M | 100.00% | AVAH ×1.08 |
| Gross profit | $319M | 51.50% | $219M | 32.59% | BOBS +18.9pp |
| Operating income | $78M | 12.67% | $80M | 11.93% | BOBS +0.7pp |
| Pre-tax income | $80M | 12.84% | $56M | 8.42% | BOBS +4.4pp |
| Net income | $58M | 9.33% | $40M | 6.01% | BOBS +3.3pp |
| Stage | BOBS | AVAH | Gap · A − B |
|---|---|---|---|
| Revenue | $620M100.00% | $670M100.00% | AVAH ×1.08 |
| Gross profit | 51.50%$319M | 32.59%$219M | BOBS +18.9pp |
| Operating income | 12.67%$78M | 11.93%$80M | BOBS +0.7pp |
| Pre-tax income | 12.84%$80M | 8.42%$56M | BOBS +4.4pp |
| Net income |
| 9.33%$58M |
| 6.01%$40M |
| BOBS +3.3pp |
No disclosed counterparties: AVAH.
None